Free Trial

R1 RCM (RCM) Competitors

R1 RCM logo
$14.28 +0.01 (+0.07%)
(As of 11/7/2024 ET)

RCM vs. TMX, MANT, PINC, FC, LH, DGX, DVA, CHE, CRVL, and AMED

Should you be buying R1 RCM stock or one of its competitors? The main competitors of R1 RCM include Terminix Global (TMX), ManTech International (MANT), Premier (PINC), Franklin Covey (FC), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), and Amedisys (AMED).

R1 RCM vs.

R1 RCM (NASDAQ:RCM) and Terminix Global (NYSE:TMX) are both mid-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, community ranking, profitability and media sentiment.

R1 RCM received 222 more outperform votes than Terminix Global when rated by MarketBeat users. However, 61.32% of users gave Terminix Global an outperform vote while only 57.17% of users gave R1 RCM an outperform vote.

CompanyUnderperformOutperform
R1 RCMOutperform Votes
287
57.17%
Underperform Votes
215
42.83%
Terminix GlobalOutperform Votes
65
61.32%
Underperform Votes
41
38.68%

Terminix Global has lower revenue, but higher earnings than R1 RCM. R1 RCM is trading at a lower price-to-earnings ratio than Terminix Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
R1 RCM$2.25B2.67$3.30M-$0.10-142.80
Terminix Global$2.05B2.25$125M$0.5371.45

61.1% of R1 RCM shares are held by institutional investors. Comparatively, 92.2% of Terminix Global shares are held by institutional investors. 36.8% of R1 RCM shares are held by insiders. Comparatively, 2.3% of Terminix Global shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

R1 RCM has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Comparatively, Terminix Global has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500.

R1 RCM currently has a consensus price target of $15.41, indicating a potential upside of 7.94%. Given R1 RCM's stronger consensus rating and higher probable upside, equities research analysts clearly believe R1 RCM is more favorable than Terminix Global.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
R1 RCM
0 Sell rating(s)
13 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.28
Terminix Global
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Terminix Global has a net margin of 3.15% compared to R1 RCM's net margin of -1.68%. Terminix Global's return on equity of 4.95% beat R1 RCM's return on equity.

Company Net Margins Return on Equity Return on Assets
R1 RCM-1.68% -1.44% -0.74%
Terminix Global 3.15%4.95%2.67%

In the previous week, R1 RCM had 7 more articles in the media than Terminix Global. MarketBeat recorded 7 mentions for R1 RCM and 0 mentions for Terminix Global. Terminix Global's average media sentiment score of 0.00 beat R1 RCM's score of -0.21 indicating that Terminix Global is being referred to more favorably in the news media.

Company Overall Sentiment
R1 RCM Neutral
Terminix Global Neutral

Summary

R1 RCM and Terminix Global tied by winning 9 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RCM vs. The Competition

MetricR1 RCMManagement services IndustryBusiness SectorNASDAQ Exchange
Market Cap$6.03B$8.32B$6.71B$8.86B
Dividend YieldN/A6.37%2.92%4.03%
P/E Ratio-142.8020.3945.3116.79
Price / Sales2.672.44321.99106.62
Price / Cash20.8416.9524.0833.93
Price / Book2.1812.884.865.72
Net Income$3.30M$155.80M$121.41M$224.20M
7 Day Performance0.14%3.88%5.48%4.17%
1 Month Performance0.49%4.15%5.69%7.85%
1 Year Performance31.73%9.81%28.43%28.75%

R1 RCM Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RCM
R1 RCM
2.875 of 5 stars
$14.28
+0.1%
$15.41
+7.9%
+31.9%$6.03B$2.25B-142.8030,000Earnings Report
TMX
Terminix Global
0.4121 of 5 stars
$37.87
flat
N/AN/A$4.61B$2.05B71.4511,700
MANT
ManTech International
N/A$95.98
flat
N/A+0.0%$3.93B$2.55B32.329,800Analyst Forecast
PINC
Premier
2.3839 of 5 stars
$21.89
+9.4%
N/A+17.0%$2.19B$1.35B21.252,900Earnings Report
Analyst Downgrade
FC
Franklin Covey
4.4771 of 5 stars
$40.68
+1.2%
N/A+3.3%$532.50M$280.52M30.361,160Analyst Downgrade
Gap Down
LH
Laboratory Co. of America
4.9021 of 5 stars
$226.52
-0.3%
N/A+15.5%$18.95B$12.16B43.8167,000Positive News
DGX
Quest Diagnostics
4.93 of 5 stars
$153.23
-0.7%
N/A+17.5%$17.10B$9.25B20.6048,000Insider Selling
Positive News
DVA
DaVita
4.3081 of 5 stars
$145.59
+0.4%
N/A+87.8%$11.94B$12.14B15.7170,000
CHE
Chemed
4.8961 of 5 stars
$531.23
+1.2%
N/A-4.4%$8.00B$2.26B26.8415,087Analyst Forecast
Gap Up
CRVL
CorVel
0.9893 of 5 stars
$303.07
+0.8%
N/A+78.5%$5.19B$795.31M67.204,870News Coverage
AMED
Amedisys
3.7871 of 5 stars
$95.31
-0.1%
N/A+4.8%$3.12B$2.29B34.0419,000Earnings Report
Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:RCM) was last updated on 11/8/2024 by MarketBeat.com Staff
From Our Partners